GO:0004532 RNA exonuclease activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004532 RNA exonuclease activity describes the catalysis of sequential cleavage of mononucleotides from a free 5' or 3' terminus of an RNA molecule.
• RNA exonucleases are essential for RNA quality control, maturation, turnover, and R-loop resolution, and their dysfunction is linked to cancer and immune disorders.
• Key human RNA exonucleases include REXO4 and REXO5, which resolve m6A-marked R-loops and maintain genomic integrity.
• Exonuclease activity is exploited in genome editing, for example in exonuclease-enhanced prime editors that improve editing efficiency.
• Assays such as ePRINT use exonuclease-assisted mapping to identify protein-RNA interactions transcriptome-wide.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of RNA exonuclease function in disease and immunity.
Description
RNA exonuclease activity (GO:0004532) is a fundamental molecular function that removes nucleotides one by one from the end of an RNA strand. This activity is distinct from endonucleolytic cleavage because it requires a free 5' or 3' terminus and proceeds sequentially, allowing precise control of RNA length and degradation. In cells, RNA exonucleases participate in nearly every aspect of RNA metabolism, from processing ribosomal and transfer RNAs to degrading aberrant transcripts and resolving RNA-DNA hybrids known as R-loops. The importance of this activity is underscored by its evolutionary conservation and by the growing list of human diseases associated with mutations in exoribonuclease genes. Beyond basic biology, RNA exonuclease activity has become a tool in biotechnology, including exonuclease-enhanced prime editing and exonuclease-assisted mapping of protein-RNA interactions. Understanding GO:0004532 therefore bridges mechanistic RNA biology, disease genetics, and cutting-edge genome engineering.
RNA exonuclease activity At A Glance
| GO ID | GO:0004532 |
|---|---|
| GO term | RNA exonuclease activity |
| Ontology | molecular_function |
| Synonym | exoribonuclease activity |
| Definition | Catalysis of the sequential cleavage of mononucleotides from a free 5' or 3' terminus of an RNA molecule. |
| Major function | Degradation and processing of RNA from either end, contributing to RNA quality control, maturation, and turnover. |
| Directionality | Acts on free 5' or 3' termini; can be 5' to 3' or 3' to 5' exonucleolytic. |
| Representative human genes | REXO4, REXO5, and other exoribonucleases involved in R-loop resolution and RNA metabolism. |
| Associated processes | R-loop resolution, anti-tumor immunity, RNA ligand generation for TLR7, and genome editing enhancement. |
What Is GO:0004532?
According to the Gene Ontology, RNA exonuclease activity (GO:0004532) is defined as the catalysis of the sequential cleavage of mononucleotides from a free 5' or 3' terminus of an RNA molecule. This means the enzyme binds to an RNA end and removes one nucleotide at a time, releasing mononucleotides, rather than cutting internally. The synonym exoribonuclease activity is often used interchangeably. This activity can act on a variety of RNA substrates, including messenger RNA, ribosomal RNA, transfer RNA, and non-coding RNAs, and it is essential for RNA quality control and turnover.
Why Is RNA exonuclease activity Important in Cell Biology?
RNA exonuclease activity is central to maintaining the correct balance of RNA species in cells. It ensures that aberrant or damaged RNAs are removed, that R-loops are resolved to prevent DNA damage, and that immune responses to RNA are properly regulated. Dysregulation of exoribonucleases can lead to genomic instability, autoimmunity, and cancer, making these enzymes attractive targets for therapeutic intervention. Moreover, the activity is harnessed in biotechnology, such as exonuclease-enhanced prime editors and ePRINT mapping, highlighting its broad impact on research and medicine.
• Maintains RNA quality control by degrading defective transcripts.
• Resolves R-loops to preserve genomic integrity and suppress DNA damage.
• Regulates immune detection of RNA by generating or destroying TLR7 ligands.
• Modulates anti-tumor immunity through m6A-marked R-loop resolution.
• Enhances prime editing efficiency when fused to genome editors.
• Enables transcriptome-wide mapping of protein-RNA interactions via ePRINT.
• Contributes to the biogenesis and turnover of circular RNAs.
• Influences lysosomal RNA processing and TLR engagement.
• Provides a mechanism for sequence-specific RNA degradation in bacteria and eukaryotes.
• Offers a target for therapeutic modulation in cancer and immune disorders.
What Happens During RNA exonuclease activity?
Substrate recognition and binding
In simple terms: The enzyme first grabs the end of an RNA molecule.
RNA exonucleases recognize free 5' or 3' termini of RNA substrates through structural domains that confer specificity for single-stranded RNA ends. This binding step ensures that the enzyme acts processively from the end rather than cleaving internally. Some exonucleases, such as REXO4 and REXO5, are recruited to specific RNA structures like R-loops, where they bind m6A-marked RNA-DNA hybrids.
Sequential cleavage of mononucleotides
In simple terms: The enzyme chews away one nucleotide at a time from the RNA end.
Once bound, the exonuclease catalyzes the hydrolysis of the phosphodiester bond at the terminus, releasing a mononucleotide and shortening the RNA by one unit. This reaction repeats processively, allowing the enzyme to degrade or trim the RNA to a defined length. The directionality can be 5' to 3' or 3' to 5', depending on the enzyme family.
R-loop resolution and genome integrity
In simple terms: Exonucleases help untangle RNA-DNA hybrids that can cause DNA breaks.
REXO4 and REXO5 are RNA exonucleases that resolve R-loops, three-stranded nucleic acid structures consisting of an RNA-DNA hybrid and displaced single-stranded DNA. REXO4 specifically targets m6A-marked R-loops, and its exonuclease activity is required to suppress anti-tumor immunity. REXO5 promotes genomic integrity by regulating R-loop levels through its exonuclease activity. Loss of these activities leads to R-loop accumulation, DNA damage, and activation of immune responses.
RNA degradation in immune sensing
In simple terms: Exonucleases control whether RNA is seen by the immune system.
Lysosomal endonuclease RNase T2 and PLD exonucleases cooperate to generate RNA ligands for TLR7 activation. Pseudouridine-modified RNA avoids immune detection through impaired endolysosomal processing and TLR engagement, a process that involves exonucleolytic activities. Thus, RNA exonucleases shape the immunostimulatory potential of RNA by controlling its degradation into or away from TLR ligands.
Exonuclease-assisted genome editing
In simple terms: Exonucleases are used in the lab to improve CRISPR editing.
Exonuclease-enhanced prime editors fuse an exonuclease domain to the prime editing machinery, which improves editing efficiency by resecting the 3' flap and promoting strand invasion. This application demonstrates how the intrinsic activity of RNA exonucleases can be repurposed for precise genome engineering.
Key Genes Involved in GO:0004532 RNA exonuclease activity
The following genes encode proteins with RNA exonuclease activity or are directly associated with GO:0004532, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| REXO4 | Resolves m6A-marked R-loops; suppresses anti-tumor immunity | Target for cancer immunotherapy; R-loop biology |
| REXO5 | Regulates R-loop resolution; maintains genomic integrity | Genome stability; leukemia research |
| RNase T2 | Lysosomal endonuclease cooperating with PLD exonucleases to generate TLR7 ligands | Innate immunity; RNA sensing |
| PLD exonucleases | Generate RNA ligands for TLR7 activation | Immune detection of RNA |
| TREX1 | 3' to 5' DNA exonuclease with roles in RNA metabolism (implied by R-loop biology) | Autoimmunity; R-loop resolution |
| XRN1 | 5' to 3' exoribonuclease involved in RNA turnover | RNA decay; quality control |
| XRN2 | 5' to 3' exoribonuclease in transcription termination | RNA processing |
| DIS3 | 3' to 5' exoribonuclease component of the exosome | RNA degradation; cancer |
| EXOSC3 | Exosome component with exoribonuclease activity | Ribosomopathy; neurodegeneration |
| EXOSC8 | Exosome component with exoribonuclease activity | Ribosomopathy; neurodegeneration |
| EXOSC9 | Exosome component with exoribonuclease activity | Ribosomopathy; neurodegeneration |
| PNPT1 | Polyribonucleotide nucleotidyltransferase; 3' to 5' exoribonuclease | RNA import; disease |
| ISG20 | 3' to 5' exonuclease induced by interferon | Antiviral immunity |
| ERI1 | 3' to 5' exoribonuclease in RNA interference | Small RNA processing |
| REXO2 | Exoribonuclease involved in RNA processing | RNA metabolism |
| PARN | Poly(A)-specific ribonuclease; 3' to 5' exonuclease | mRNA deadenylation; disease |
| CNOT6 | CCR4-NOT complex exonuclease subunit | mRNA decay |
How Is RNA exonuclease activity Regulated?
RNA exonuclease activity is regulated at multiple levels. Subcellular localization, post-translational modifications, and interaction with accessory proteins control enzyme recruitment to specific RNA substrates. For example, REXO4 and REXO5 are recruited to R-loops in a manner dependent on RNA modifications such as m6A. In immune cells, the generation of TLR7 ligands by RNase T2 and PLD exonucleases is regulated by endolysosomal trafficking and RNA modifications like pseudouridine. Additionally, exonuclease activity can be modulated by fusion to genome editing proteins to enhance prime editing. These regulatory layers ensure that RNA degradation is spatially and temporally controlled.
RNA exonuclease activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| REXO4 | Cancer; anti-tumor immunity | Knockout in cancer cell lines; syngeneic mouse models |
| REXO5 | Leukemia; genomic instability | Knockout in leukemia cell lines; patient-derived xenografts |
| RNase T2 | Autoimmunity; TLR7 activation | Knockout in immune cells; TLR7 reporter assays |
| EXOSC3 | Ribosomopathy; neurodegeneration | Knockout in neuronal cells; patient iPSC-derived neurons |
| PARN | Dyskeratosis congenita; mRNA deadenylation defects | Knockout in hematopoietic stem cells; zebrafish models |
Cancer and anti-tumor immunity
REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity; loss of REXO4 leads to R-loop accumulation and increased immune detection of tumors. REXO5 promotes genomic integrity by regulating R-loops, and its dysfunction is associated with leukemia. These findings link RNA exonuclease activity directly to cancer development and immunotherapy response.
Autoimmunity and RNA sensing
Defects in RNA exonuclease activity can lead to the accumulation of immunostimulatory RNA species that activate TLR7 and other innate immune sensors. Pseudouridine-modified RNA avoids immune detection through impaired endolysosomal processing and TLR engagement, highlighting how exonucleolytic processing determines immune tolerance to RNA. Dysregulation of these pathways is implicated in autoimmune diseases such as systemic lupus erythematosus.
Neurodegeneration and ribosomopathies
Mutations in exosome components with exoribonuclease activity, such as EXOSC3, EXOSC8, and EXOSC9, cause ribosomopathies and neurodegeneration. These disorders underscore the critical role of RNA exonuclease activity in ribosomal RNA processing and neuronal survival.
From RNA exonuclease activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of REXO4 affect R-loop levels and immune response? | REXO4 knockout cell lines and mouse models |
| Is the exonuclease activity of REXO5 required for genomic integrity? | Point mutation in the exonuclease domain of REXO5 |
| How does m6A modification recruit REXO4 to R-loops? | Knock-in of m6A reader mutants; tagged REXO4 |
| Can exonuclease-enhanced prime editors improve editing efficiency? | Knock-in of exonuclease domain into prime editor |
| What is the role of RNase T2 in TLR7 ligand generation? | RNase T2 knockout macrophages; overexpression of PLD exonucleases |
| How does pseudouridine modification affect RNA immune detection? | Overexpression of pseudouridine-modified RNA; TLR7 reporter cells |
How to Study the RNA exonuclease activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ePRINT | Protein-RNA interactions transcriptome-wide | Mapping RNA-binding protein targets |
| DRIP-seq | R-loop formation genome-wide | Assessing REXO4/REXO5 function |
| RNA-seq | RNA abundance and processing | Measuring RNA turnover upon exonuclease perturbation |
| TLR7 reporter assay | Innate immune activation by RNA | Testing RNase T2 and PLD exonuclease function |
| Pseudouridine RNA processing assay | Endolysosomal stability and TLR engagement | Studying immune evasion by modified RNA |
| Prime editing efficiency assay | Genome editing precision | Evaluating exonuclease-enhanced prime editors |
| Circular RNA detection | Circular RNA abundance | Linking exonuclease activity to circRNA metabolism |
| Single-strand-specific nuclease assay | Exonuclease activity in vitro | Characterizing enzyme kinetics |
Exonuclease-assisted mapping of protein-RNA interactions (ePRINT)
ePRINT uses exonuclease activity to map protein-RNA interactions transcriptome-wide by digesting unprotected RNA and sequencing the protected fragments. This method provides nucleotide-resolution footprints of RNA-binding proteins and can be applied to study exonucleases themselves.
R-loop detection and quantification
R-loops can be detected using the S9.6 antibody or by native gel electrophoresis, and their levels are quantified in cells with modulated RNA exonuclease activity. DRIP-seq and R-ChIP are used to map R-loops genome-wide.
RNA sequencing and degradation assays
RNA-seq and targeted degradation assays measure the half-life and processing of specific RNAs upon exonuclease knockout or overexpression. These methods reveal the substrate specificity and processivity of exonucleases.
Immune activation assays
TLR7 reporter assays and cytokine profiling are used to assess how RNA exonuclease activity affects innate immune activation by RNA ligands. Pseudouridine-modified RNA can be tested for impaired endolysosomal processing and TLR engagement.
How CRISPR Can Be Used to Study GO:0004532 RNA exonuclease activity
Knockout
CRISPR knockout of RNA exonuclease genes such as REXO4 or REXO5 enables loss-of-function studies to assess their roles in R-loop resolution, genomic integrity, and immune responses. Knockout cell lines can be used for RNA-seq, DRIP-seq, and immune assays.
Point Mutation
Point mutations in the catalytic domain of exonucleases, such as REXO5, allow separation of exonuclease activity from other functions. CRISPR-mediated point mutation can introduce precise amino acid changes to test catalytic residues.
Knock-in
Knock-in of tags (e.g., FLAG, GFP) into endogenous exonuclease loci facilitates localization and interaction studies. Knock-in of m6A reader mutants can dissect recruitment mechanisms.
Overexpression
Overexpression of wild-type or mutant exonucleases, such as RNase T2 or PLD exonucleases, can test gain-of-function effects on TLR7 ligand generation and immune activation. Overexpression of pseudouridine-modified RNA can assess immune evasion.
How EDITGENE Supports RNA exonuclease activity Research
Researchers studying RNA exonuclease activity-related genes often need to determine whether a candidate gene is causally involved in RNA metabolism, R-loop resolution, or immune regulation. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for RNA exonuclease activity research.
Frequently Asked Questions About RNA exonuclease activity
What is RNA exonuclease activity?
RNA exonuclease activity (GO:0004532) is the catalysis of the sequential cleavage of mononucleotides from a free 5' or 3' terminus of an RNA molecule.
What genes are involved in RNA exonuclease activity?
Key genes include REXO4, REXO5, RNase T2, PLD exonucleases, and exosome components such as EXOSC3, EXOSC8, and EXOSC9.
How does RNA exonuclease activity differ from endonuclease activity?
Exonucleases cleave from the end of RNA sequentially, while endonucleases cut internally.
What diseases are linked to RNA exonuclease dysfunction?
Cancer, autoimmunity, neurodegeneration, and ribosomopathies have been linked to defects in RNA exonuclease activity.
How is RNA exonuclease activity measured?
It can be measured using in vitro degradation assays, RNA-seq, DRIP-seq for R-loops, and ePRINT for protein-RNA interactions.
Can RNA exonuclease activity be used in genome editing?
Yes, exonuclease-enhanced prime editors improve editing efficiency by resecting the 3' flap.
What is the role of REXO4 in immunity?
REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity.
How does REXO5 maintain genomic integrity?
REXO5 regulates R-loop resolution through its exonuclease activity, preventing DNA damage.
What is ePRINT?
ePRINT is an exonuclease-assisted method for mapping protein-RNA interactions transcriptome-wide.
How can CRISPR help study RNA exonuclease activity?
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of exonuclease function in cells and animals.
Conclusion
RNA exonuclease activity (GO:0004532) is a fundamental molecular function that governs RNA processing, quality control, and genome stability. Its dysregulation is implicated in cancer, autoimmunity, and neurodegeneration, and its enzymatic properties are exploited in genome editing and RNA mapping technologies. Continued research using CRISPR-engineered models will further illuminate the mechanistic and therapeutic relevance of this activity.
References
- 1. Jeck WR et al.. 2013. Circular RNAs are abundant, conserved, and associated with ALU repeats.. RNA 19(2):141-57 PMID: 23249747
- 2. Bérouti M et al.. 2025. Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement.. Cell 188(18):4880-4895.e15 PMID: 40580950
- 3. Bérouti M et al.. 2024. Lysosomal endonuclease RNase T2 and PLD exonucleases cooperatively generate RNA ligands for TLR7 activation.. Immunity 57(7):1482-1496.e8 PMID: 38697119
- 4. Zhang J et al.. 2026. RNA exonuclease REXO4 resolves m(6)A-marked R-loops and suppresses anti-tumor immunity.. Mol Cell 86(15):2998-3016.e17 PMID: 42476127
- 5. Lee YJ et al.. 2024. REXO5 promotes genomic integrity through regulating R-loop using its exonuclease activity.. Leukemia 38(10):2150-2161 PMID: 39080354
- 6. Truong DJ et al.. 2024. Exonuclease-enhanced prime editors.. Nat Methods 21(3):455-464 PMID: 38302659
- 7. Desai NA et al.. 2003. Single-strand-specific nucleases.. FEMS Microbiol Rev 26(5):457-91 PMID: 12586391
- 8. Hawkins S et al.. 2024. ePRINT: exonuclease assisted mapping of protein-RNA interactions.. Genome Biol 25(1):140 PMID: 38807229
